JP Morgan Chase’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3M | Sell |
31,800
-10,000
| -24% | -$5.43M | ﹤0.01% | 2312 |
|
|
2025
Q4 | $24.2M | Buy |
41,800
+16,400
| +65% | +$9.27M | ﹤0.01% | 1902 |
|
|
2025
Q3 | $12.3M | Sell |
25,400
-10,800
| -30% | -$5.03M | ﹤0.01% | 2535 |
|
|
2025
Q2 | $14.7M | Buy |
36,200
+29,200
| +417% | +$12.2M | ﹤0.01% | 2207 |
|
|
2025
Q1 | $3.48M | Sell |
7,000
-61,400
| -90% | -$33.3M | ﹤0.01% | 3459 |
|
|
2024
Q4 | $35.6M | Buy |
68,400
+39,000
| +133% | +$21.4M | ﹤0.01% | 1543 |
|
|
2024
Q3 | $18.2M | Buy |
29,400
+1,000
| +4% | +$592K | ﹤0.01% | 2073 |
|
|
2024
Q2 | $15.7M | Buy |
28,400
+2,900
| +11% | +$1.66M | ﹤0.01% | 2055 |
|
|
2024
Q1 | $14.8M | Buy |
25,500
+500
| +2% | +$281K | ﹤0.01% | 2144 |
|
|
2023
Q4 | $13.3M | Buy |
25,000
+20,000
| +400% | +$9.68M | ﹤0.01% | 2194 |
|
|
2023
Q3 | $2.53M | Sell |
5,000
-45,000
| -90% | -$24M | ﹤0.01% | 3387 |
|
|
2023
Q2 | $26.1M | Sell |
50,000
-8,000
| -14% | -$4.32M | ﹤0.01% | 1508 |
|
|
2023
Q1 | $33.4M | Buy |
58,000
+27,900
| +93% | +$15.7M | ﹤0.01% | 1314 |
|
|
2022
Q4 | $16.6M | Buy |
30,100
+4,100
| +16% | +$2.17M | ﹤0.01% | 1813 |
|
|
2022
Q3 | $13.2M | Sell |
26,000
-3,900
| -13% | -$2.18M | ﹤0.01% | 1936 |
|
|
2022
Q2 | $16.2M | Sell |
29,900
-9,000
| -23% | -$4.95M | ﹤0.01% | 1781 |
|
|
2022
Q1 | $23M | Hold |
38,900
| – | – | ﹤0.01% | 1661 |
|
|
2021
Q4 | $26M | Buy |
38,900
+11,400
| +41% | +$7.12M | ﹤0.01% | 1606 |
|
|
2021
Q3 | $15.7M | Buy |
27,500
+19,100
| +227% | +$10.5M | ﹤0.01% | 1966 |
|
|
2021
Q2 | $4.24M | Buy |
+8,400
| New | +$3.96M | ﹤0.01% | 3202 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$233K | – | 6354 |
|
|
2020
Q4 | $233K | Hold |
500
| – | – | ﹤0.01% | 4759 |
|
|
2020
Q3 | $217K | Hold |
500
| – | – | ﹤0.01% | 4323 |
|
|
2020
Q2 | $181K | Hold |
500
| – | – | ﹤0.01% | 4312 |
|
|
2020
Q1 | $142K | Sell |
500
-26,400
| -98% | -$8.32M | ﹤0.01% | 4405 |
|
|
2019
Q4 | $8.74M | Sell |
26,900
-14,000
| -34% | -$4.25M | ﹤0.01% | 2223 |
|
|
2019
Q3 | $11.9M | Hold |
40,900
| – | – | ﹤0.01% | 1989 |
|
|
2019
Q2 | $12M | Sell |
40,900
-30,100
| -42% | -$8.29M | ﹤0.01% | 1952 |
|
|
2019
Q1 | $19.4M | Sell |
71,000
-11,300
| -14% | -$2.81M | ﹤0.01% | 1557 |
|
|
2018
Q4 | $18.4M | Buy |
82,300
+51,800
| +170% | +$12.2M | ﹤0.01% | 1543 |
|
|
2018
Q3 | $7.44M | Sell |
30,500
-6,700
| -18% | -$1.54M | ﹤0.01% | 2439 |
|
|
2018
Q2 | $7.71M | Buy |
+37,200
| New | +$7.9M | ﹤0.01% | 2347 |
|
|
2017
Q3 | – | Sell |
-41,800
| Closed | -$7.29M | – | 5185 |
|
|
2017
Q2 | $7.29M | Sell |
41,800
-37,200
| -47% | -$6.25M | ﹤0.01% | 2205 |
|
|
2017
Q1 | $12.1M | Buy |
+79,000
| New | +$12.1M | ﹤0.01% | 1792 |
|
|
2016
Q1 | – | Sell |
-200,000
| Closed | -$28.4M | – | 4939 |
|
|
2015
Q4 | $28.4M | Hold |
200,000
| – | – | 0.01% | 1104 |
|
|
2015
Q3 | $24.5M | Hold |
200,000
| – | – | 0.01% | 1144 |
|
|
2015
Q2 | $26M | Buy |
+200,000
| New | +$26.1M | 0.01% | 1241 |
|
Other funds holding TMO
VCM
VPM
JP Morgan Chase's TMO Position: Q1 2026 in Review
JP Morgan Chase increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q1 2026, buying an estimated $99.6M and bringing the position to 6,795,482 shares worth $3.26B. The position accounts for 0.21% of the portfolio, ranked #103.
JP Morgan Chase first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.04B in Q1 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- JP Morgan Chase held 6,795,482 shares of Thermo Fisher Scientific worth $3.26B as of Q1 2026.
- JP Morgan Chase bought 183,604 Thermo Fisher Scientific shares in Q1 2026, an estimated $99.6M.
- Thermo Fisher Scientific made up 0.21% of JP Morgan Chase's portfolio in Q1 2026, its #103 holding.
- JP Morgan Chase first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Thermo Fisher Scientific position peaked at $5.04B in Q1 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.